The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
Abstract
&NA; Colloidal systems based on lipids have attracted attention during the last two decades as a delivery method of drugs that are poorly soluble in water. The investigations carried out have focused on the development of different formulations using a wide variety of excipients and active molecules. However, there is no consensus on the structure of the particles in these colloidal systems. This is partly due since there are few studies oriented to understand both the preferential location of the drug in the particle and the arrangement of the lipids and the stabilizing agents during the particle formation. As a contribution in this sense, in this review the most common materials and preparation methods to obtain lipid particles are presented. Also, the particle characteristics, including the shape, size and size distribution, zeta potential, drug load capacity and drug entrapment efficiency are synthesized and analyzed with the help of scientometrics tools. Emphasis has been placed on the latest advances regarding the particle structure especially as it relates to the drug release behavior. In addition to the available evidence, a model of particle structure based on the formation of the different polymorphic forms of the solid lipid because of the starting materials and the processing conditions is proposed. In general, the importance of obtaining a detailed knowledge of the structure of the lipid nanoparticles is highlighted, which is useful for the rational design of this type of nanocarriers and propose solutions to the challenges involved in their formulation. Graphical abstract Figure. No caption available. HighlightsThe common materials and preparation methods to obtain lipid particles are presented.The main characteristics of lipid nanoparticles are synthesized.The proposed models of particle structure are analyzed in a comparative way.The relation between the nanoparticle structure and the drug release is investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–224 of 224
Dan, N. R. (2014) · Langmuir · doi:10.1021/la5030197 · Cited by 49
Solid Lipid Nanoparticles in Drug Delivery
Deshpande, A., Mohamed, M., Daftardar, S. B., Patel, M., Boddu, S. H. S., & Nesamony, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00012-7 · Cited by 49
Impact of Lipid Physical State on the Oxidation of Methyl Linolenate in Oil-in-Water Emulsions
Okuda, S., McClements, D. J., & Decker, E. A. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0518960 · Cited by 47
Lacerda, S. D. P., Cerize, N. N. P., & Ré, M. I. (2011) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00626.x · Cited by 45
Pegi, A., Kristl, J., Pečar, S., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10277 · Cited by 44
Montenegro, L., Sarpietro, M. G., Ottimo, S., Puglisi, G., & Castelli, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.076 · Cited by 44
Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles
Illing, A., & Unruh, T. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.017 · Cited by 41
Charoenputtakun, P., Li, S. K., & Ngawhirunpat, T. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.094 · Cited by 38
Keskin, S., Besztejan, S., Kassier, G. H., Manz, S., Bücker, R., Riekeberg, S., Trieu, H. K., Rentmeister, A., & Miller, R. J. D. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.5b02075 · Cited by 37
Mazuryk, J., Deptuła, T., Polchi, A., Gapiński, J., Giovagnoli, S., Magini, A., Emiliani, C., Kohlbrecher, J., & Patkowski, A. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.05.017 · Cited by 35
Li, Z., Yu, L., Zheng, L., & Geng, F. (2009) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-009-0127-z · Cited by 34
Negi, J. S., Chattopadhyay, P., Sharma, A. K., & Ram, V. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0154-y · Cited by 33
Boreham, A., Volz, P., Peters, D., Keck, C. M., & Alexiev, U. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.020 · Cited by 30
Haag, S. F., Chen, M., Peters, D., Keck, C. M., Taskoparan, B., Fahr, A., Teutloff, C., Bittl, R., Lademann, J. M., Schäfer‐Korting, M., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.10.009 · Cited by 29
Torrecilla, J., del Pozo‐Rodríguez, A., Apaolaza, P. S., Solinís, M. Á., & Rodríguez‐Gascón, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.047 · Cited by 27
Drug distribution in nanostructured lipid particles
Saeidpour, S., Lohan, S. B., Solik, A., Paul, V., Bodmeier, R. A., Zoubari, G., Unbehauen, M. L., Haag, R., Bittl, R., Meinke, M. C., et al. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.008 · Cited by 26
Tosta, F. V., Andrade, L. M., Mendes, L. P., dos Anjos, J. L. V., Alonso, A., Marreto, R. N., Lima, E. M., & Taveira, S. F. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2782-7 · Cited by 23
Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel
Baek, J.-S., Shin, S., & Cho, C. (2012) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-012-0038-z · Cited by 20
Videira, M., Arranja, A., & Gouveia, L. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.005 · Cited by 19
How Lipid Cores Affect Lipid Nanoparticles as Drug and Gene Delivery Systems
Radaic, A., Barbosa, L. R. S., Jaime, C., Kapila, Y. L., Pessine, F. B. T., & de Jesus, M. B. (2016) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2016.04.001 · Cited by 15
Milsmann, J., Oehlke, K., Greiner, R., & Steffen‐Heins, A. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.05.050 · Cited by 15
Liquid Crystalline Phase Formation in Suspensions of Solid Trimyristin Nanoparticles
Gehrer, S., Schmiele, M., Westermann, M., Steiniger, F., & Unruh, T. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506787v · Cited by 13
Büyükköroğlu, G., Şenel, B., Gezgin, S., & Dinh, T. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.06.010 · Cited by 13
Sivaramakrishnan, R., Kankate, L., Niehus, H., & Kramer, K. D. (2004) · Biophysical Chemistry · doi:10.1016/j.bpc.2004.12.007 · Cited by 7
Cited by
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Lipid Nanoparticles for Drug Delivery
Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C.-X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 545
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Bayón-Cordero, L., Alkorta, I., & Arana, L. (2019) · Nanomaterials · doi:10.3390/nano9030474 · Cited by 344
SLN and NLC for topical, dermal, and transdermal drug delivery
Souto, E. B., Baldim, I., Oliveira, W. P., Rao, R., Yadav, N., Gama, F. M., & Mahant, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727883 · Cited by 328
Metadata
- Authors
- Gordillo-Galeano, A., & Mora-Huertas, C. E.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 133
- Pages
- 285-308
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2898146268
- Cited by
- 569
- References
- 224
- FWCI
- 17.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.